Nucleus RadioPharma

Nucleus RadioPharma is a full-service contract development and manufacturing organization (CDMO) specializing in targeted radiotherapies. They provide end-to-end services, supporting both biotech startups and pharmaceutical companies throughout the entire development and manufacturing process, from initial research and development to clinical trials and commercial production. Their focus is on building robust and reliable supply chains for these innovative cancer treatments, overcoming the unique challenges of working with radioisotopes and ensuring safe, effective, and accessible therapies for patients.

Nucleus RadioPharma is backed by leading organizations in the field, including the Mayo Clinic, Eclipse Ventures, and AstraZeneca. They have a team of seasoned industry experts with over 150 collective years of experience in manufacturing and 250 collective years of experience in radiopharmaceutical supply chains. Their vision is to transform cancer care by making groundbreaking, minimally invasive radiotherapies the new norm for patients worldwide.

Nucleus RadioPharma offers a competitive benefits package for its employees, including unlimited PTO for eligible team members. This demonstrates a commitment to work-life balance and flexible work arrangements.

Nucleus RadioPharma offers a competitive compensation package, including a thorough health insurance plan that begins on the first day of employment for eligible employees. They also offer a 401(k) plan with a 4% company match after one month of employment and unlimited PTO for eligible employees.

Nucleus RadioPharma is a contract development and manufacturing organization (CDMO) dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies. Their mission is to transform scientific potential into reality by helping innovators overcome the challenges of working with radioisotopes to deliver safe, effective, and accessible treatments to redefine cancer care. They aim to elevate cancer treatment to unprecedented levels of precision and efficacy, making groundbreaking, minimally invasive therapies the new norm for patients worldwide.

Nucleus RadioPharma promotes a collaborative and results-oriented culture, driven by a shared passion for advancing cancer care. Their focus on attracting industry experts with a deep knowledge of radiopharmaceuticals fosters a learning environment where employees contribute to the company's success. They emphasize the importance of communication and teamwork to overcome the unique challenges of working with radioactive isotopes and bring life-saving therapies to patients faster.

Nucleus RadioPharma is committed to building a diverse, equitable, and inclusive workplace that reflects the communities it serves. They strive to create an environment where all employees feel respected, valued, and empowered to contribute their unique perspectives and talents. This commitment is evident in their diverse leadership team and board of directors, with representation from various backgrounds and experiences. They actively recruit and retain a diverse workforce through targeted outreach programs and inclusive hiring practices. Nucleus recognizes that a diverse and inclusive workplace fosters innovation, strengthens decision-making, and ultimately benefits patients by providing them with the best possible care.